Contact Information
Company Information
Company
Translational Drug Development (TD2)
Annual Revenue
15000000.0
Technologies
Outlook
Microsoft Office 365
WP Engine
Hubspot
Google Tag Manager
Facebook Widget
Linkedin Widget
Linkedin Login
Shutterstock
Google Font API
Hotjar
Jobscore
DoubleClick Conversion
Facebook Login (Connect)
Linkedin Marketing Solutions
DoubleClick
Bootstrap Framework
Google Dynamic Remarketing
Google AdSense
WordPress.org
Mobile Friendly
Remote
Keywords
xenograft models
bioanalytical services
primary gbm panel
ariiel radiation lab
oncology clinical trial management
ind filings
regulatory affairs
fda interactions
data management
preclinical oncology
translational drug development
flow cytometry
adc drug development
radiopharmaceutical drug development
syngeneic studies
immunooncology
pdx models
humanized pdx
research services
clinical trial services
study design
protocol development
patient identification
site management
regulatory support
biostatistics
pharmacovigilance
medical monitoring
etmf management
quality assurance
therapeutic areas
radiolabeled pharmaceuticals
hematologic malignancies
full program management
consulting
protocol design
program budget
executive plan
trial enablement
regulatory writing
submission filing
gap analysis
model systems
syngeneic tumor models
orthotopic tumor models
patient derived xenograft
humanized mouse models
diet-induced obesity models
adoptive cell therapy models
dmpk/adme services
in vivo characterization
in vitro characterization
optical imaging
therapeutic evaluation
antibody drug conjugates
clinical study management
pk/adme
innovative cancer therapies
precision oncology
oncology cro
clinical trial metrics
data quality assurance
adverse event reconciliation
system validation
cdisc compliance
oncology drug development
contract research organization
clinical trial management
preclinical services
advanced flow cytometry
targeted therapies
immuno-oncology
antibody-drug conjugates
radiopharmaceuticals
precision medicine
clinical trial execution
biomarker discovery
translational research
community oncology practices
patient access
drug development ecosystem
strategic collaboration
scientific innovation
patient outcomes
clinical trial sites
biopharmaceutical companies
oncology research
operational excellence
global clinical trials
patient-derived xenografts
pharmacokinetics
safety profiling
fda compliance
oncology therapies
cancer treatment acceleration
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans